De Castro Javier, Hernández-Hernández Angel, Rodríguez Marina C, Sardina José L, Llanillo Marcial, Sánchez-Yagüe Jesús
Radiology Service, Santísima Trinidad Foundation Hospital, Salamanca, Spain.
Platelets. 2007 Feb;18(1):43-51. doi: 10.1080/09537100600800776.
To analyse and compare the phospholipid and fatty acid composition of total lipids and the occurrence of lipid peroxidation and protein oxidation directly in erythrocytes or platelets from chronic obstructive pulmonary disease (COPD) and asthma patients.
Fifteen consecutive outpatients with COPD (all smokers) and asthma (non-smokers) recruited during a moderate-to-severe (COPD) or moderate (asthma) exacerbation. Fifteen subjects with smoking habits similar to those of COPD patients were studied as a control group.
Phospholipid and total fatty acid compositions were analysed by two-dimensional thin layer chromatography or gas chromatography-mass spectrometry, respectively. The lipid fluorescence of lipid extracts was measured by spectrofluorimetry. Protein carbonyl contents and profiles were measured by immunoblot detection.
No differences were found either in erythrocyte or platelet cholesterol or phospholipid levels. Only a decrease in the content of phosphatidylserine + phosphatidylinositol (P<0.003) was detected in platelets from the asthma patients. In erythrocytes, the fatty acid profile changed in both lung pathologies, especially as regards polyunsaturated fatty acids (decreases in arachidonic and 22:4 fatty acid contents). Other observed changes were: COPD, an increase in palmitic fatty acid; asthma, an increase in oleic and decreases in eicosapentaenoic and 22:6 + 24:1 fatty acids. In platelets, the fatty acid profiles revealed many differences between both lung pathologies: COPD, a decrease in 18:1 and increases in 20:5 and 22:5 + 24:0; asthma, a decrease in 20:4 and increase in 22:6 + 24:1. In COPD vs. asthma patients, fatty acid changes were mainly detected in platelets, especially in 18-carbon species, with decreases in stearic and 18:1 fatty acids in the COPD patients. Protein oxidation levels were increased in both lung pathologies in both erythrocytes and platelets.
COPD and asthma are associated with common or specific changes in the lipid composition of erythrocytes and/or platelets. The data point to lipid peroxidation and protein oxidation phenomena in both types of blood cell, although platelets would be more susceptible to stress.
分析并比较慢性阻塞性肺疾病(COPD)和哮喘患者红细胞或血小板中总脂质的磷脂和脂肪酸组成,以及脂质过氧化和蛋白质氧化的发生情况。
连续纳入15例中度至重度(COPD)或中度(哮喘)加重期的门诊COPD患者(均为吸烟者)和哮喘患者(非吸烟者)。选取15名吸烟习惯与COPD患者相似的受试者作为对照组。
分别采用二维薄层色谱法或气相色谱 - 质谱法分析磷脂和总脂肪酸组成。通过荧光分光光度法测定脂质提取物的脂质荧光。通过免疫印迹检测法测定蛋白质羰基含量和谱图。
在红细胞或血小板的胆固醇或磷脂水平上未发现差异。仅在哮喘患者的血小板中检测到磷脂酰丝氨酸 + 磷脂酰肌醇含量降低(P<0.003)。在红细胞中,两种肺部疾病均出现脂肪酸谱改变,尤其是多不饱和脂肪酸方面(花生四烯酸和22:4脂肪酸含量降低)。其他观察到的变化包括:COPD患者棕榈酸增加;哮喘患者油酸增加,二十碳五烯酸以及22:6 + 24:1脂肪酸减少。在血小板中,两种肺部疾病的脂肪酸谱显示出许多差异:COPD患者18:1减少,20:5以及22:5 + 24:0增加;哮喘患者20:4减少,22:6 + 24:1增加。与哮喘患者相比,COPD患者的脂肪酸变化主要在血小板中检测到,尤其是18碳脂肪酸,COPD患者的硬脂酸和18:1脂肪酸减少。在两种肺部疾病中,红细胞和血小板中的蛋白质氧化水平均升高。
COPD和哮喘与红细胞和/或血小板脂质组成的共同或特定变化有关。数据表明两种血细胞中均存在脂质过氧化和蛋白质氧化现象,尽管血小板可能更容易受到应激影响。